Suppliers / Merck Sante

Merck Sante

France Updated 9 July 2026

Merck Sante is an API and finished-dose manufacturer based in France. It holds 2 active US drug master files. Its filings concentrate with ANSM (FR), ANPP (DZ) and DAV (Vietnam). Its GMP standing is certified by ANSM (FR), EMA and NAFDAC (NG), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 25 October 2024 as VAI.

2
active US DMFs
0
valid CEPs
9
registered plants 3 with an FDA FEI number
97
filings across 11 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
3 of 3 confirmed
Inspections
8 of 8 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 25 October 2024 VAI US FDA
  • 23 September 2022 VAI US FDA
  • 17 November 2021 VAI US FDA
  • 19 July 2018 NAI US FDA
  • 11 July 2018 NAI US FDA
  • 14 June 2018 NAI US FDA
  • 21 June 2016 VAI US FDA
  • 3 June 2014 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
SEMOY, United Arab Emirates Not on file
CALAIS, France Not on file
France, France 3002807502
Semoy, France Not on file
France, France 3002807504
France, France 3002807474

3 further sites are on record.

What they file, and where

Filings and GMP by regulator

Regulator Filings GMP certificates
ANSM (FR) 42 45
ANPP (DZ) 11 None
DAV (Vietnam) 10 None
DIGEMAPS (DO) 9 None
SFDA (Saudi Arabia) 6 None
EDA (EG) 6 None
EMA None 3
NAFDAC (NG) None 1
US FDA None 1

Scale

Year Revenue Exports Destinations
2023 $676.6M Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Comparing suppliers?

Choose your molecules and target markets. Merck Sante comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 25 October 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported